Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease

Published:2018-05 Issue: Volume:133 Page:385-394
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Feng Peng,Zhang Xiangjian,Li Dongfang,Ji Chenhui,Yuan Ziyue,Wang Ruifang,Xue Guofang,Li Guanglai,Hölscher Christian

Funder

‘100 Foreign Expert’ scheme of the Shanxi province government

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference71 articles.

1. The GDNF family: signalling, biological functions and therapeutic value;Airaksinen;Nat. Rev. Neurosci.,2002

2. GDNF, NGF and BDNF as therapeutic options for neurodegeneration;Allen;Pharmacol. Ther.,2013

3. Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial;Athauda;Lancet,2017

4. Exenatide and the treatment of patients with Parkinson's disease;Aviles-Olmos;J. Clin. Invest.,2013

5. Motor and cognitive advantages persist 12 Months after exenatide exposure in Parkinson's disease;Aviles-Olmos;J. Parkinson's Dis.,2014

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond insulin: The Intriguing role of GLP-1 in Parkinson's disease;European Journal of Pharmacology;2024-11

2. Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson's and Alzheimer's disease clinical trials: A revolution in the making?;Neuropharmacology;2024-08

3. Current Therapeutic Options and Repurposed Drugs for Neurodegeneration;Advances in Diagnostics and Immunotherapeutics for Neurodegenerative Diseases;2024-07-28

4. Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration;Biomolecules;2024-07-19

5. A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson’s disease;Scientific Reports;2024-07-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3